News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hopfner Robert Lorne
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/03/2023 |
4
| Hopfner Robert Lorne (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Bought 119,048 shares
@ $4.8, valued at
$571.4k
Bought 714,285 shares
@ $4.8, valued at
$3.4M
|
|
| 05/19/2023 |
4
| Hopfner Robert Lorne (Director) has filed a Form 4 on Rallybio Corp|
Txns:
| Granted 15,490 options to buy
@ $5.64, valued at
$87.4k
|
|
| 05/15/2023 |
4
| Hopfner Robert Lorne (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Bought 219,230 shares
@ $6.48, valued at
$1.4M
Bought 228,702 shares
@ $6.25, valued at
$1.4M
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Hopfner Robert Lorne (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 9,367 options to buy
@ $4.38, valued at
$41k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2022 |
4
| Hopfner Robert Lorne (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Bought 1,070,000 shares
@ $3.69, valued at
$3.9M
|
|
| 01/05/2022 |
4
| Hopfner Robert Lorne (Director) has filed a Form 4 on Rallybio Corp|
Txns:
| Granted 6,242 options to buy
@ $10.38, valued at
$64.8k
|
|
| 08/04/2021 |
4
| Hopfner Robert Lorne (Director) has filed a Form 4 on Rallybio Corp|
Txns:
| Acquired 1,694,388 shares
@ $0
Bought 576,923 shares
@ $13, valued at
$7.5M
Disposed of 10,789,193 options to buy
@ $0
Granted 13,440 options to buy
@ $13, valued at
$174.7k
|
|
| 07/29/2021 |
3
| Hopfner Robert Lorne (Director) has filed a Form 3 on Rallybio Corp |
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Hopfner Robert Lorne (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 50,874 shares
@ $25.64, valued at
$1.3M
Sold 28,922 shares
@ $26.06, valued at
$753.7k
Sold 38,248 shares
@ $27.12, valued at
$1M
Sold 88,756 shares
@ $28.07, valued at
$2.5M
Sold 93,740 shares
@ $28.75, valued at
$2.7M
Sold 37,271 shares
@ $25.75, valued at
$959.7k
Sold 26,688 shares
@ $26.78, valued at
$714.7k
Sold 7,567 shares
@ $27.64, valued at
$209.2k
Sold 6,632 shares
@ $28.66, valued at
$190.1k
|
|
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2021 |
4
| Hopfner Robert Lorne (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 19,511 shares
@ $25.61, valued at
$499.7k
Sold 15,461 shares
@ $26.07, valued at
$403.1k
Sold 16,769 shares
@ $25.23, valued at
$423.1k
Sold 1,373 shares
@ $26.13, valued at
$35.9k
Sold 2,140 shares
@ $25.3, valued at
$54.1k
|
|
| 01/22/2021 |
4
| Hopfner Robert Lorne (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 19,046 shares
@ $25.35, valued at
$482.8k
Sold 100 shares
@ $25.11, valued at
$2.5k
Sold 11,383 shares
@ $25.16, valued at
$286.4k
|
|
| 01/19/2021 |
4
| Hopfner Robert Lorne (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Sold 14,918 shares
@ $25.88, valued at
$386.1k
Sold 22,869 shares
@ $25.74, valued at
$588.6k
Sold 3,808 shares
@ $26.05, valued at
$99.2k
Sold 42,516 shares
@ $25.55, valued at
$1.1M
Sold 7,000 shares
@ $26.05, valued at
$182.4k
|
|
| 01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2020 |
4
| Hopfner Robert Lorne (10% Owner) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Converted 1,403,654 shares
@ $0
Bought 187,500 shares
@ $16, valued at
$3M
Converted 10,489,510 convertible preferred
@ $0 |
|
| 07/24/2020 |
4
| Hopfner Robert Lorne (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 9,367 options to buy
@ $16, valued at
$149.9k
|
|
| 07/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/16/2020 |
4
| Hopfner Robert Lorne (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Converted 1,692,494 shares
@ $0
Converted 226,236 shares
@ $0
Converted 211,237 shares
@ $0
Bought 93,000 shares
@ $16, valued at
$1.5M
Converted 1,692,494 options to buy
@ $0
Converted 226,236 options to buy
@ $0
Converted 211,237 options to buy
@ $0 |
|
| 06/15/2020 |
4
| Hopfner Robert Lorne (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 40,000 options to buy
@ $16, valued at
$640k
|
|
| 06/11/2020 |
3
| Hopfner Robert Lorne (Director) has filed a Form 3 on Vaxcyte, Inc. |
| 07/25/2012 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|